Gary S Firestein

University of California, San Diego

NIH Rank #251
  • Program Leader
  • Top 5% Funded
  • R01 Holder
  • Early Career
  • Mentor
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$12.1M
Fiscal year 2024
Grants Awarded
6
Active NIH grants
National Rank
#251
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $12.1M across 6 grants · National rank #251.

Top grants by award amount

Gary S Firestein's NIH grant portfolio, ranked by award amount.

  • 5UL1TR001442-10UL1
    UC San Diego Clinical and Translational Research Institute
    $9.2M
    award amount
  • 5U01AR079717-03U01
    Methotrexate treatment of Arthritis caused by Chikungunya virus (MARCH): A randomized controlled trial of methotrexate versus placebo in the treatment of chronic arthritis after chikungunya infection
    $1.5M
    award amount
  • 5R01AR065466-10R01
    Identification of key regulators in rheumatoid arthritis
    $555.1K
    award amount
  • 2T32AR064194-11T32
    Rheumatic Diseases Research Training Grant
    $376K
    award amount
  • 3UL1TR001442-10S1UL1
    UC San Diego Clinical and Translational Research Institute
    $216.9K
    award amount
  • 3U01AR079717-03S1U01
    Methotrexate treatment of Arthritis caused by Chikungunya virus (MARCH): A randomized controlled trial of methotrexate versus placebo in the treatment of chronic arthritis after chikungunya infection
    $148.4K
    award amount

Affiliations

Institutions that have administered grants for Gary S Firestein.

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    University of California, San Diego
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    $10M Cumulative Funding
  7. 2024
    Entered Top 50% Nationally
    Ranked #251
  8. 2024
    Entered Top 25% Nationally
    Ranked #251
  9. 2024
    Entered Top 10% Nationally
    Ranked #251
  10. 2024
    Entered Top 5% Nationally
    Ranked #251
  11. 2024
    Multi-Institutional Research
    Awards at 2 institutions